"May this festival of happiness...":Amit Shah, Rajnath Singh extend warm Holi wishes to countrymen

During April 2024, Coal India Limited (CIL) achieved a coal production of 61.78 million tonnes (MT) marking a growth of 7.31 per cent compared to the same period last year when it was 57.57 MT.

Additionally, coal production by captive/others in April 2024 stood at 11.43 MT, reflecting a growth of 12.99 per cent compared to the previous year's production of 10.12 MT.

India's coal dispatches for April 2024 reached 85.10 MT, up 6.07 per cent compared to the same period last year when it was recorded at 80.23 MT.

During April 2024, CIL dispatched 64.26 MT of coal, with a growth of 3.18 per cent compared to the corresponding period of the previous year when it was 62.28 MT.

Additionally, coal dispatch by captive/others in April was recorded at 15.16 MT (Provisional), reflecting a growth of 26.9 per cent from the previous year, which was 11.95 MT. (IANS) 

Read More National News 

The Hyderabad-based company issued a statement amid questions being raised in some quarters over the safety of Covid vaccines after global pharmaceutical manufacturer AstraZeneca admitted that its Covid vaccine Covishield, developed by researchers from Oxford University, can cause a rare side effect of blood clotting and low platelet count after immunisation.

As many as 175 crore doses of Covishield, developed by AstraZeneca and manufactured by Pune-based Serum Institute, were reportedly administered in India.

Bharat Biotech mentioned that Covaxin was the only Covid-19 vaccine in the Indian government’s Covid-19 immunisation programme to have conducted efficacy trials in India.

"Covaxin was evaluated in more than 27,000 subjects as part of its licensure process. It was licensed under restricted use in clinical trial mode, where detailed safety reporting was carried out for several hundred thousand subjects," the vaccine manufacturer said.

The safety of Covaxin was also evaluated by the Ministry of Health.

"Ongoing safety monitoring (pharmacovigilance) was continued throughout the product life cycle of Covaxin. All the above studies and safety follow-up activities have demonstrated an excellent safety record for Covaxin without any vaccine-associated incidents of blood clots, Thrombocytopenia, TTS, VITT, pericarditis, myocarditis, etc.," it said.

"As seasoned innovators and product developers, the Bharat Biotech team was well aware that, while the efficacy of Covid-19 vaccines may be short-lived, the impact on patient safety could last a lifetime. Hence safety is the primary focus for all our vaccines," it added. (IANS) 

Read More Business News

A delegation led by Commerce Secretary Sunil Barthwal visited New Zealand on April 26-27 and held a number of constructive meetings with the Minister for Trade of New Zealand, Todd McClay.

The 11th India-New Zealand Joint Trade Committee (JTC) meeting was also held to work on ways to deepen the existing bilateral relations.

Both countries discussed the creation of working groups for sectors like pharmaceuticals, agriculture, food processing, storage and transportation.

Collaboration in the pharmaceuticals and medical devices sector was discussed at length, including the adoption of fast-tracking of regulatory processes and quality assessment of manufacturing facilities using, as appropriate, the inspection reports of comparable overseas regulators.

Greater sourcing of medicines from India and cooperation in the medical device sector were also discussed, according to a Commerce Ministry statement.

The discussions also included cooperation in the horticulture sector, including cooperation in the kiwi fruit sector (quality & productivity, proper storage in pack houses and their suitable transportation) as well as the dairy sector.

Once working groups are established, India and New Zealand will review the progress made by them and the recommendations thereof at regular intervals.

The meetings addressed bilateral trade matters of mutual interest, including issues related to market access, non-tariff barriers (NTBs), and sanitary and phytosanitary (SPS) measures on products like grapes, okra, and mangoes,

The services sector and enhancing its scale for bilateral trade was given special focus during the discussions held at various levels, which revealed great interest from both sides for increasing business-to-business as well as people-to-people contacts and to work on the skill gaps and how the same can be strengthened through capacity building and improving the ease of mobility. (IANS) 

Read More Business News